These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21320476)

  • 21. Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis.
    Iguchi T; Hasegawa T; Otsuka K; Matsumoto K; Yamazaki T; Nishimura S; Nakata S; Ehara S; Kataoka T; Shimada K; Yoshiyama M
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):284-91. PubMed ID: 24022065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Saydam GS; Dogan M; Ulupinar H; Aydin C; Topcu DI; Sasmaz A
    Coron Artery Dis; 2008 Mar; 19(2):79-84. PubMed ID: 18300743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Adiponectin Resistance on Coronary Artery Disease Severity.
    Stojanovic S; Ilic MD; Ilic S; Saric S; Stojanovic S; Petrovic V
    Niger J Clin Pract; 2021 Aug; 24(8):1240-1246. PubMed ID: 34397037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease.
    Granér M; Syvänne M; Kahri J; Nieminen MS; Taskinen MR
    Ann Med; 2007; 39(2):137-44. PubMed ID: 17453676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
    Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
    Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population.
    Yoon SE; Ahn SG; Kim JY; Park JS; Shin JH; Tahk SJ; Lee SK; Kim TJ; Han N
    J Korean Med Sci; 2011 Jul; 26(7):900-5. PubMed ID: 21738343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score.
    Konstantinou DM; Chatzizisis YS; Louridas GE; Giannoglou GD
    Metab Syndr Relat Disord; 2010 Jun; 8(3):201-8. PubMed ID: 20156070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic score for insulin resistance predicts major adverse cardiovascular event in premature coronary artery disease.
    Guo D; Zhang C; Zhang M; Wu Z; Liu X; Zhang Y; Liu L; Sun M; Yang J
    Aging (Albany NY); 2024 Apr; 16(7):6364-6383. PubMed ID: 38568104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance.
    Esteghamati A; Ashraf H; Esteghamati AR; Meysamie A; Khalilzadeh O; Nakhjavani M; Abbasi M
    Diabetes Res Clin Pract; 2009 Jun; 84(3):279-87. PubMed ID: 19359063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different definitions of the metabolic syndrome.
    Sandhofer A; Iglseder B; Paulweber B; Ebenbichler CF; Patsch JR
    Eur J Clin Invest; 2007 Feb; 37(2):109-16. PubMed ID: 17217376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterations.
    Solymoss BC; Bourassa MG; Marcil M; Levesque S; Varga S; Campeau L
    Coron Artery Dis; 2009 Jan; 20(1):1-8. PubMed ID: 19050599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Metabolic Syndrome on Subclinical Atherosclerosis in Asymptomatic Individuals.
    Park GM; An H; Lee SW; Cho YR; Gil EH; Her SH; Park HW; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Park SW; Park SJ
    Circ J; 2015; 79(8):1799-806. PubMed ID: 25959307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome.
    Koji Y; Tomiyama H; Yamada J; Yambe M; Motobe K; Shiina K; Yamashina A
    Hypertens Res; 2007 Mar; 30(3):243-7. PubMed ID: 17510506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
    Akçay AB; Camsarı A; Ozcan T; Ciçek D; Akkuş N; Seyis S; Cimen B; Celebi B; Döven O; Cin G
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):371-7. PubMed ID: 21743260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area.
    Vilar CP; Cotrim HP; Florentino GS; Bragagnoli G; Schwingel PA; Barreto CP
    Arq Gastroenterol; 2015; 52(2):111-6. PubMed ID: 26039828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
    Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
    J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women.
    Nilsson G; Hedberg P; Jonason T; Lönnberg I; Tenerz A; Forberg R; Ohrvik J
    Eur J Intern Med; 2008 Nov; 19(7):520-6. PubMed ID: 19013381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.